All In Biotech

Drug Trial Radar · NCT06431594

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Subjects With Advanced Solid Tumors

Last checked: Nov 20, 2026Latest source record: Jun 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 675 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

675

Planned (sponsor's estimate)

Start

Jul 2, 2024

Primary completion

Sep 22, 2027

Study completion Dec 31, 2029

Sponsor

Lead sponsor
GlaxoSmithKlineGSK (GSK)
Sponsor type
Industry
First posted
May 28, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to assess the safety and tolerability of Mocertatug Rezetecan . The study will also see how the levels of Mo-Rez change over time at different dose amount

Conditions

  • Solid Tumors
  • Neoplasms

Interventions

  • Mocertatug rezetecanDrug

    Mocertatug rezetecan will be administered

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part 1: Number of participants with dose limiting toxicity (DLT)Time frame: Up to 21 days
  2. Part 2-Confirmed Objective Response Rate (ORR) assessed by investigatorTime frame: Up to approximately 28 months

Locations

65 sites in 15 countries. Site status is shown where the registry gives one.

  • GSK Investigational Site

    Birmingham, Alabama · Recruiting

  • GSK Investigational Site

    Fountain Valley, California · Recruiting

  • GSK Investigational Site

    Santa Rosa, California · Recruiting

  • GSK Investigational Site

    Lake Mary, Florida · Completed

  • GSK Investigational Site

    Orlando, Florida · Recruiting

  • GSK Investigational Site

    Fairway, Kansas · Recruiting

  • GSK Investigational Site

    Boston, Massachusetts · Recruiting

  • GSK Investigational Site

    Boston, Massachusetts · Recruiting

  • GSK Investigational Site

    Detroit, Michigan · Recruiting

  • GSK Investigational Site

    Grand Rapids, Michigan · Recruiting

  • GSK Investigational Site

    Minneapolis, Minnesota · Recruiting

  • GSK Investigational Site

    Mineola, New York · Recruiting

  • GSK Investigational Site

    New York, New York · Recruiting

  • GSK Investigational Site

    Portland, Oregon · Recruiting

  • GSK Investigational Site

    Nashville, Tennessee · Recruiting

  • GSK Investigational Site

    Dallas, Texas · Recruiting

  • GSK Investigational Site

    West Valley City, Utah · Recruiting

  • GSK Investigational Site

    Seattle, Washington · Recruiting

  • GSK Investigational Site

    Cipoletti Rio Negro, Argentina · Recruiting

  • GSK Investigational Site

    Ciudad de Buenos Aires, Argentina · Recruiting

  • GSK Investigational Site

    La Plata, Argentina · Recruiting

  • GSK Investigational Site

    Rosario, Argentina · Recruiting

  • GSK Investigational Site

    Blacktown, New South Wales, Australia · Recruiting

  • GSK Investigational Site

    Macquarie University, New South Wales, Australia · Recruiting

  • GSK Investigational Site

    Leuven, Belgium · Recruiting

  • GSK Investigational Site

    Barretos, Brazil · Recruiting

  • GSK Investigational Site

    Goiânia, Brazil · Recruiting

  • GSK Investigational Site

    Rio de Janeiro, Brazil · Recruiting

  • GSK Investigational Site

    Ottawa, Ontario, Canada · Recruiting

  • GSK Investigational Site

    Toronto, Ontario, Canada · Recruiting

  • GSK Investigational Site

    Toronto, Ontario, Canada · Recruiting

  • GSK Investigational Site

    Montreal, Quebec, Canada · Recruiting

  • GSK Investigational Site

    Montreal, Quebec, Canada · Recruiting

  • GSK Investigational Site

    Helsinki, Finland · Recruiting

  • GSK Investigational Site

    Helsinki, Finland · Recruiting

  • GSK Investigational Site

    Tampere, Finland · Recruiting

  • GSK Investigational Site

    Lyon, France · Recruiting

  • GSK Investigational Site

    Saint-Herblain, France · Recruiting

  • GSK Investigational Site

    Villejuif, France · Recruiting

  • GSK Investigational Site

    Aviano PN, Italy · Recruiting

Showing 40 of 65 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.